About
Hello everyone, I am a highly analytical professional with comprehensive experience in…
Articles by David
-
Are you poised to take advantage of #JCAHO's recent decision?
Are you poised to take advantage of #JCAHO's recent decision?
Many healthcare systems like EHRs, telehealth providers and medication management solutions are not ready to take…
1 Comment
Activity
5K followers
-
David Means reposted thisDavid Means reposted thisEvery second counts when delivering life-saving insights to clinicians. The FDA has granted Breakthrough Device Designation for CARE™ Chest X-Ray (CXR) Triage, now officially 510(k) submitted! This marks the third FDA Breakthrough Device Designation in just over a year. Powered by CARE, healthcare's first clinical-grade foundation model, this is another major leap forward in our development velocity, allowing us to deliver meaningful solutions to clinical teams faster than ever. Chest X-rays are the world’s most common imaging exam, but sheer volume creates a constant challenge for care teams. Built to fit seamlessly into existing workflows, CARE CXR Triage is designed to automatically flag suspected urgent findings with the potential to help health systems elevate care quality, clear backlogs faster, and improve patient outcomes. Read how we’re shaping the future of diagnostic AI: https://lnkd.in/d9qw4_Yy *The device received breakthrough device designation by FDA, and is now under FDA review and 510(k) pending, not currently available for sale in the U.S.
-
David Means reposted thisReal healthcare transformation happens when best-in-class technologies work together inside a single system, compounding each other's impact for care providers and patients alike. We are thrilled to partner with Summa Health, Health Assurance Transformation Company (HATCo), General Catalyst and an incredible group of ecosystem leaders, to unveil Summa’s new technology transformation stack. Together, we are making a long-term commitment to reshape care delivery across the Greater Akron region. Our focus is creating smoother day-to-day operations for care providers while turning patient signals into actionable insights. Most importantly, we are building toward a more connected, seamless experience for every patient, serving as a blueprint for broader healthcare transformation across the country. Proud to work alongside Daryl Tol, Hemant Taneja and incoming Summa CEO Jennifer Eslinger, MBA, FACHE, and the entire team on this shared vision.David Means reposted thisIn 2024, we made the unprecedented decision to acquire a hospital system. It was an opportunity to create a blueprint for healthcare transformation to make American healthcare proactive, accessible, and affordable. Summa Health and our Health Assurance Transformation Company (HATCo) revealed their technology transformation stack, partnering with some of our portfolio companies Aidoc, Clarium, Commure, Fabric, Hippocratic AI, Judi Health, Transcarent, and Verse Medical. Percepta is serving as a transformation partner, unifying the tech stack into a seamless Al-native operating system. We believe the future of healthcare is health assurance with tech founders and health system leaders working together to reimagine healthcare in the US and beyond.
-
David Means reposted thisDavid Means reposted thisWe’re proud to announce a successful clinical go-live with Stamford Health, featuring the enterprise-wide integration of Aidoc’s aiOS™ to deliver AI insights across 16 distinct use cases into radiologist workflows, assisting in the flagging of critical imaging findings improving diagnostic outcomes and patient care. Stamford Health saw the real-world impact immediately, sharing that Aidoc is providing peace of mind during high-stress shifts. Dr. Ronald Lee, Chair of Radiology at Stamford Health, highlighted how the operating system supports their team by helping streamline care coordination and case prioritization during high-volume shifts. He noted that while it doesn't replace their meticulous workflow, having automated notifications for suspected findings running in the background is invaluable for prioritizing time-sensitive cases, especially when covering the ED and managing massive patient volumes. Moments like these highlight exactly why these implementations are so meaningful in showing how AI can optimize workflows and support physicians when they need it most. A huge thank you to the Stamford team for the incredible partnership, energy, and collaboration that made this milestone possible!
-
David Means reposted thisDavid Means reposted thisCMS just made it easier for hospitals to budget for our AI. Starting October 1st, Aidoc’s CARE™ Body CT Multi-Triage solution is eligible for the New Technology Add-on Payment (NTAP) program, allowing health systems to code qualifying inpatient cases for additional Medicare reimbursement. We’ve always focused on building AI that delivers both clinical impact and a clear financial return on investment. Now, that value is further strengthened by a defined reimbursement pathway that can help offset adoption costs and support broader scale. Clinical value. Financial value. And now, reimbursement to ease the dilemma even further. https://lnkd.in/eSH49zJ3
-
David Means reposted thisDavid Means reposted thisHealthcare lives by "do no harm." Tech lives by "move fast." Finding the right path forward requires doing it together. That’s why 12 of the largest US health systems and Aidoc are teaming up to launch the Diagnostic AI Consortium. A first-of-its-kind collaboration defining, validating, and co-designing workflows to accelerate the future of diagnostic AI straight from the front lines of care. Building safe, effective diagnostic AI isn't something any tech company or health system can do on its own. It requires real-world governance, continuous iteration, and an uncompromised focus on quality of care. Real-world testing in real clinical workflows, built by the physicians and care teams who rely on it every day. Together, these health systems care for 20 million patient lives annually, defining how AI actually gets deployed where it matters most. Learn more about the Consortium and our mission: https://lnkd.in/eB_9vnd2 Advocate Health, Cedars-Sinai, Hartford HealthCare, Mercy, Mount Sinai Health System, Northwell Health, Northwestern Medicine, Sutter Health, UF Health, University Hospitals of Cleveland, WellSpan Health Elad Walach
-
David Means reposted thisDavid Means reposted this“Clinical AI is the seat belt of medicine, and it has to earn that same trust much faster, precisely because adoption is moving so fast.” Thank you, Joyce Famakinwa and Modern Healthcare, for profiling our CEO and co-founder, Elad Walach, on clinical AI’s biggest hurdle: trust. Read the full story here: https://lnkd.in/d4ncnm7GAidoc’s rise reflects clinical AI’s next big hurdleAidoc’s rise reflects clinical AI’s next big hurdle
-
David Means reposted thisA big milestone for Houston Methodist as they continue to push the boundaries of AI in care delivery. We’re especially proud of what this means for patients: better support for care teams to surface suspected acute findings faster and act sooner. Houston Methodist continues to lead in AI innovation, now earning a spot on Modern Healthcare's 2026 15 Top Health Systems list. We're incredibly proud to be part of their continued momentum. Thank you to the Houston Methodist team for the partnership and trust. Excited for what’s ahead.David Means reposted thisAnd we’re off!!! ☺️ Kudos to all the clinicians, super users, IT, the Steering Committee, System leaders and most especially our Executive Sponsor Roberta Schwartz for an amazing start to a new chapter on our innovation journey! Aidoc has been wonderful to work with and patiently have guided us along the way #LeadingMedicine #HoustonMethodist
-
David Means reposted thisDavid Means reposted thisDiagnostic AI just took a massive leap forward. First Read has officially secured FDA Breakthrough Device Designation*, our second in under a year! By bringing our clinical-grade foundation model directly into radiology reporting, our goal is to tackle the massive imaging bottleneck and shift how diagnostic radiologists manage growing demand. Here is what the industry is saying: 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗗𝗶𝘃𝗲 “Reduces time spent on reporting while preserving radiologist oversight and final approval.“ “Generate preliminary reports on more than 100 pre-specified findings**” 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗜𝗺𝗮𝗴𝗶𝗻𝗴 "Radiology is entering a new era." 𝗠𝗼𝗱𝗲𝗿𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 “FDA grants Breakthrough Device designation for Aidoc’s radiology AI” 𝗔𝘂𝗻𝘁 𝗠𝗶𝗻𝗻𝗶𝗲 “Aidoc's second Breakthrough Device Designation in under a year” We hope to fundamentally shift how diagnostic radiologists manage growing demand. This is just the beginning. Link to the news in the comments. *Breakthrough Device Designation Q260882. The device is for investigational use only and has not been cleared or approved by the FDA. **First Read is a broad chest radiograph analysis solution, with Breakthrough Device Designation (Q260882) granted for four life-threatening findings.
-
David Means shared thisIn honor of Pride Month, I wanted to share Aidoc’s Global CMO and the AMA’s first openly gay President, though on Pride, healthcare, family, and the future of AI.Pride, Care, & Innovation: In conversation with Dr. Jesse Ehrenfeld - Aidoc | Clinical AIPride, Care, & Innovation: In conversation with Dr. Jesse Ehrenfeld - Aidoc | Clinical AI
-
David Means liked thisSome stories remind you why the work matters. Carolyn's is definitely one of them. Every day, teams across Aidoc — engineering, product, analytics, clinical value, commercial marketing and more work behind the scenes toward one mission: to improve patient care with Clinical AI. We build it, we educate on it and we tell its story. Today we get to tell my favorite kind of story: the human one. Carolyn could be any of us — a parent, a partner, a friend. Most of us will have medical imaging at some point. When we do, we want to know our care team has the tools to find what matters and act on it fast. At WellSpan Health they do. They're showing what care looks like when clinical AI supports care teams every day. Thank you to the WellSpan team for your partnership and to Carolyn for allowing us to share your story!David Means liked thisCarolyn rang the bell for the second time. At 82, she'd beaten cancer again and was ready to get back to camping trips, family time and the active life she shares with her husband of 62 years. Then a routine follow-up scan found something unexpected: a suspected blood clot in her lung. Through WellSpan Health's use of Aidoc, the suspected finding was flagged and prioritized, notifying the clinical care team so they could confirm and coordinate care immediately. Within about an hour, Carolyn's care team was reaching out. She went to WellSpan York Hospital and received treatment the same day. Carolyn's story shows the human impact of faster imaging workflows and what our partnership with WellSpan Health is built to support across the health system. Since implementing Aidoc in 2023, WellSpan has cut outpatient critical-case imaging turnaround time from 25 hours to about two hours. More than 6,000 patients have benefited from earlier case prioritization across over 1.7 million scans analyzed to date. Carolyn is just one of those patients, who have benefited from WellSpan Health’s innovative use of technology and dedication to putting its patients first. See Carolyn and Dr. Lim pictured recently below. Learn how Aidoc and WellSpan Health are supporting more coordinated care: https://lnkd.in/dUz6Sm23
-
David Means liked thisDavid Means liked thisCarolyn finished six rounds of chemo and rang the bell for the second time. Her follow-up CT scan was meant to just be a routine scan. It wasn’t. Aidoc flagged a suspected pulmonary embolism, a potentially life threatening condition. Within an hour, her care team at WellSpan Health had a plan. By the time she arrived at WellSpan York Hospital, they were ready to start treatment. An algorithm surfacing a finding is step one, but it goes nowhere without a health system committed to building the workflows to act on it. WellSpan has done exactly this: since going live with Aidoc in 2023, the team reports cutting outpatient critical-case imaging turnaround from 25 hours to ~2. Across 1.7 million scans, more than 6,000 patients have had their cases prioritized. Behind each of those numbers is someone just like Carolyn. Cancer treatment already demands so much of patients and their families, and it's a sacred duty to provide the best available care. Helping health systems deliver on that promise when patients need it most is why we do this work. Thank you to the WellSpan Health team for building this with us, and to Carolyn for sharing your story. Read Carolyn's story here: https://lnkd.in/e6QjaDxk
-
David Means liked thisDavid Means liked thisAn AI alert is not a patient outcome. At Newsweek's AI Health Summit in New York, I was encouraged by how often the conversation moved beyond what the technology can do to what *actually* changes for patients. As a physician that is the question I care about most. Finding an abnormality is only the beginning. Does the right clinician see it? Is someone responsible for the next step? Does the patient receive appropriate care sooner? Without those connections, more detection can simply create more unfinished work. The discussions reinforced something central to my work at Aidoc: clinical AI implementation needs to be a care delivery effort, with technology supporting it. That means involving physicians, nurses & operational teams from the start, designing reliable handoffs, and measuring whether care actually improves not just whether a tool gets used. Administrative efficiency matters. But we should be just as ambitious about preventing harm, shortening delays in diagnosis & treatment and giving clinicians more time to care for people. I was especially encouraged by the discussion about sharing implementation lessons across health systems. We should not all have to rediscover the same workflow challenges independently! Sharing what works, what fails & how we evaluate performance should be part of the work particularly to help extend the benefits to rural and less resourced settings. I left energized by the possibilities but also reminded of our responsibility to distinguish enthusiasm from evidence. The goal is not a hospital with more AI. It is a health system where fewer patients fall through the cracks. Thank you to Newsweek and the clinicians, health system leaders & innovators who brought such practical perspectives to the conversation. #PatientSafety #ClinicalAI #HealthcareInnovation
-
David Means liked thisDavid Means liked thisThe countdown is on! Two weeks until #Australia, #NewZealand and RANZCR! 🇦🇺🇳🇿 I’ll be in #Melbourne Oct 15–17, #Sydney Oct 18–20, and #Christchurch Oct 20–26. Looking forward to meeting radiologists, clinicians, CIOs and healthcare leaders across the region, and especially to The Royal Australian & New Zealand College of Radiologists (RANZCR) 2026, where Amitai Mandelbaum and I will be showcasing Aidoc aiOS™ in action: one clinical AI operating system that brings multiple AI solutions together, built to scale. We’ll also be sharing exciting updates on First Read, our CARE™-powered innovation for preliminary chest X-ray reports, and the latest in Oncology AI. Schedule a meeting with us here: https://lnkd.in/dDW58Gx9
-
David Means liked thisDavid Means liked thisOne of the clearest themes in healthcare AI right now is that building the technology is only part of the challenge. The harder work is making it something clinicians can trust, rely on and use at scale. Joshua Streit, AVP of Digital Transformation at Aidoc, shares his perspective on what that actually looks like in practice, from the role of foundation models to building systems that are responsible, accessible and useful across very different care environments. We’re grateful to have Aidoc supporting the UT REAL Health AI Symposium and bringing an important perspective to the conversations happening in Austin. Looking forward to continuing the discussion on October 7–8 #UTRealHealthAI
-
David Means liked thisDavid Means liked thisCarolyn rang the bell for the second time. At 82, she'd beaten cancer again and was ready to get back to camping trips, family time and the active life she shares with her husband of 62 years. Then a routine follow-up scan found something unexpected: a suspected blood clot in her lung. Through WellSpan Health's use of Aidoc, the suspected finding was flagged and prioritized, notifying the clinical care team so they could confirm and coordinate care immediately. Within about an hour, Carolyn's care team was reaching out. She went to WellSpan York Hospital and received treatment the same day. Carolyn's story shows the human impact of faster imaging workflows and what our partnership with WellSpan Health is built to support across the health system. Since implementing Aidoc in 2023, WellSpan has cut outpatient critical-case imaging turnaround time from 25 hours to about two hours. More than 6,000 patients have benefited from earlier case prioritization across over 1.7 million scans analyzed to date. Carolyn is just one of those patients, who have benefited from WellSpan Health’s innovative use of technology and dedication to putting its patients first. See Carolyn and Dr. Lim pictured recently below. Learn how Aidoc and WellSpan Health are supporting more coordinated care: https://lnkd.in/dUz6Sm23
-
David Means liked thisDavid Means liked thisEvery second counts when delivering life-saving insights to clinicians. The FDA has granted Breakthrough Device Designation for CARE™ Chest X-Ray (CXR) Triage, now officially 510(k) submitted! This marks the third FDA Breakthrough Device Designation in just over a year. Powered by CARE, healthcare's first clinical-grade foundation model, this is another major leap forward in our development velocity, allowing us to deliver meaningful solutions to clinical teams faster than ever. Chest X-rays are the world’s most common imaging exam, but sheer volume creates a constant challenge for care teams. Built to fit seamlessly into existing workflows, CARE CXR Triage is designed to automatically flag suspected urgent findings with the potential to help health systems elevate care quality, clear backlogs faster, and improve patient outcomes. Read how we’re shaping the future of diagnostic AI: https://lnkd.in/d9qw4_Yy *The device received breakthrough device designation by FDA, and is now under FDA review and 510(k) pending, not currently available for sale in the U.S.
-
David Means liked thisDavid Means liked thisOur CEO Elad Walach recently joined Newsweek CEO Circle to break down where clinical AI is actually heading and how it is reshaping modern health systems right now. In the feature, Elad dives into the real-world reality of healthcare AI, moving past the hype to focus on clinical-grade foundation models, safe enterprise deployment, and why AI is built to empower physicians rather than replace them. He explores how intelligent workflows are cutting diagnostic delays, improving treatment coordination, and elevating patient care at scale across more than 1,500 health systems globally. Catch the full conversation on Newsweek: https://lnkd.in/d_h5Vdfy
Licenses & Certifications
Recommendations received
3 people have recommended David
Join now to viewOther similar profiles
Explore more posts
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content